Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Megna Michael R exercised options for 7,564 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Jan 15 to Apr 1, 2026 · Filed Apr 3, 2026
From Jan 15 to Apr 1, 2026, Megna Michael R (CHIEF ACCOUNTING OFFICER) exercised options for 7,564 Kiniksa Pharmaceuticals International, Plc shares, leaving 31,777 shares. Filed Apr 3, 2026 (Form 4).
- Options exercised
- 7,564 shares
- Holding after
- 31,777 shares
- Trading plan
- No
- Role
- CHIEF ACCOUNTING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Class A Ordinary Share | Award | 372 | US$24.16 | 27,418 | Direct |
| Apr 1, 2026 | Class A Ordinary Share | Option exercise | 7,564 | 34,982 | Direct | |
| Apr 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 3,205 | US$48.13 | 31,777 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Megna Michael R
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Megna Michael R · Apr 13, 2026
- Form 4 · Megna Michael R · Apr 8, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026